Exacta BioScience has secured a $1 million USD financing round to accelerate the development of its bacteriophage-based crop-protection platform.
The investment supports Exacta’s mission to connect cutting-edge biological innovation with the agricultural industry — advancing product development, scale-up capacity and the path to registration for the company’s pipeline.
The round reflects growing confidence in biological alternatives that offer effective, residue-free protection for high-value crops.